Free Trial

TRACON Pharmaceuticals (TCON) Insider Trading & Ownership

TRACON Pharmaceuticals logo
$0.04
0.00 (0.00%)
(As of 11/5/2024 ET)

TRACON Pharmaceuticals (NASDAQ:TCON) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.27%
Number Of
Insiders Buying
(Last 3 Years)
3
Amount Of
Insider Buying
(Last 3 Years)
$2.94 M
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$2,188.80
Get TCON Insider Trade Alerts

Want to know when executives and insiders are buying or selling TRACON Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TCON Insider Buying and Selling by Quarter

TRACON Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/26/2023Charles TheuerCEOBuy199$13.20$2,626.80  
3/9/2023Opaleye Management Inc.Major ShareholderBuy8,725$27.60$240,810.00  
2/28/2023Charles TheuerCEOBuy10$30.40$304.00  
1/18/2023Charles TheuerCEOBuy340$32.40$11,016.00  
12/14/2022Charles TheuerCEOBuy1,150$25.80$29,670.00  
12/14/2022Opaleye Management Inc.Major ShareholderBuy8,375$25.00$209,375.00  
12/6/2022Opaleye Management Inc.Major ShareholderSell76$28.80$2,188.80  
11/18/2022Charles TheuerCEOBuy695$28.20$19,599.00  
11/2/2022Charles TheuerCEOBuy300$31.80$9,540.00  
10/18/2022Opaleye Management Inc.Major ShareholderBuy625$33.00$20,625.00  
10/7/2022Charles TheuerCEOBuy250$35.40$8,850.00  
10/3/2022Charles TheuerCEOBuy250$33.40$8,350.00  
9/29/2022Opaleye Management Inc.Major ShareholderBuy470$34.80$16,356.00  
9/27/2022Opaleye Management Inc.Major ShareholderBuy85$33.80$2,873.00  
9/22/2022Charles TheuerCEOBuy250$35.20$8,800.00  
9/22/2022Opaleye Management Inc.Major ShareholderBuy865$34.60$29,929.00  
9/19/2022Opaleye Management Inc.Major ShareholderBuy250$37.40$9,350.00  
9/12/2022Scott B BrownCFOBuy125$40.40$5,050.00  
7/26/2022Opaleye Management Inc.Major ShareholderBuy112$34.40$3,852.80  
7/22/2022Charles TheuerCEOBuy225$37.00$8,325.00  
7/14/2022Opaleye Management Inc.Major ShareholderBuy359$36.20$12,995.80  
7/12/2022Charles TheuerCEOBuy150$37.40$5,610.00  
6/24/2022Opaleye Management Inc.Major ShareholderBuy570$27.80$15,846.00  
6/21/2022Opaleye Management Inc.Major ShareholderBuy42,099$26.20$1,102,993.80  
5/10/2022Opaleye Management Inc.Major ShareholderBuy485$35.20$17,072.00  
5/9/2022Charles TheuerCEOBuy500$37.00$18,500.00  
5/6/2022Charles TheuerCEOBuy125$39.40$4,925.00  
4/29/2022Charles TheuerCEOBuy250$39.40$9,850.00  
4/25/2022Opaleye Management Inc.Major ShareholderBuy538$43.60$23,456.80  
4/22/2022Opaleye Management Inc.Major ShareholderBuy2,100$44.80$94,080.00  
4/21/2022Charles TheuerCEOBuy225$46.00$10,350.00  
4/13/2022Opaleye Management Inc.Major ShareholderBuy367$50.00$18,350.00  
4/11/2022Opaleye Management Inc.Major ShareholderBuy455$48.40$22,022.00  
4/8/2022Charles TheuerCEOBuy100$50.00$5,000.00  
3/30/2022Charles TheuerCEOBuy200$54.00$10,800.00  
3/29/2022Scott B BrownCFOBuy50$56.40$2,820.00  
3/21/2022Charles TheuerCEOBuy60$49.00$2,940.00  
1/28/2022Opaleye Management Inc.Major ShareholderBuy25$44.00$1,100.00  
1/24/2022Opaleye Management Inc.Major ShareholderBuy868$41.00$35,588.00  
1/21/2022Opaleye Management Inc.Major ShareholderBuy1,750$43.80$76,650.00  
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

1/19/2022Opaleye Management Inc.Major ShareholderBuy1,184$44.80$53,043.20  
12/29/2021Opaleye Management Inc.Major ShareholderBuy2,616$50.20$131,323.20  
12/27/2021Opaleye Management Inc.Major ShareholderBuy4,366$58.40$254,974.40  
12/15/2021Opaleye Management Inc.Major ShareholderBuy1,098$48.60$53,362.80  
12/13/2021Opaleye Management Inc.Major ShareholderBuy760$52.80$40,128.00  
12/6/2021Opaleye Management Inc.Major ShareholderBuy1,136$45.20$51,347.20  
12/3/2021Opaleye Management Inc.Major ShareholderBuy4,463$46.00$205,298.00  
11/18/2021Charles TheuerCEOBuy34$57.60$1,958.40  
11/5/2021Charles TheuerCEOBuy200$68.20$13,640.00  
(Data available from 1/1/2013 forward)

TCON Insider Trading Activity - Frequently Asked Questions

The list of insiders at TRACON Pharmaceuticals includes Charles Theuer, Opaleye Management Inc., and Scott B Brown. Learn more on insiders at TCON.

5.27% of TRACON Pharmaceuticals stock is owned by insiders. Learn more on TCON's insider holdings.

The following insiders have purchased TCON shares in the last 24 months: Charles Theuer ($63,215.80), and Opaleye Management Inc. ($450,185.00).

Insiders have purchased a total of 19,494 TCON shares in the last 24 months for a total of $513,400.80 bought.

The following insider sold TCON shares in the last 24 months: Opaleye Management Inc. ($2,188.80).

Insiders have sold a total of 76 TRACON Pharmaceuticals shares in the last 24 months for a total of $2,188.80 sold.

TRACON Pharmaceuticals Key Executives

  • Dr. Charles P. Theuer M.D. (Age 60)
    Ph.D., Chairman, CEO & President
    Compensation: $646.6k
  • Mr. Scott B. Brown CPA (Age 43)
    M.S., Chief Financial Officer
    Compensation: $403.1k
  • Dr. James L. Freddo M.D. (Age 69)
    Chief Medical Officer
  • Mr. Ya Huang
    Executive Director of Statistical Programming


This page (NASDAQ:TCON) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners